1172 related articles for article (PubMed ID: 26043152)
1. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
2. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
3. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
[TBL] [Abstract][Full Text] [Related]
4. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
5. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
[TBL] [Abstract][Full Text] [Related]
6. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
7. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Cardiovasc Interv Ther; 2018 Jul; 33(3):247-255. PubMed ID: 28643214
[TBL] [Abstract][Full Text] [Related]
8. Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis.
Pilgrim T; Stortecky S; Nietlispach F; Heg D; Tueller D; Toggweiler S; Ferrari E; Noble S; Maisano F; Jeger R; Roffi M; Grünenfelder J; Huber C; Wenaweser P; Windecker S
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27856487
[TBL] [Abstract][Full Text] [Related]
9. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation.
Gonska B; Seeger J; Baarts J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
J Cardiol; 2017 Jun; 69(6):877-882. PubMed ID: 27614379
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
[TBL] [Abstract][Full Text] [Related]
12. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
13. The extent of aortic annulus calcification is a predictor of postprocedural eccentricity and paravalvular regurgitation: a pre- and postinterventional cardiac computed tomography angiography study.
Bekeredjian R; Bodingbauer D; Hofmann NP; Greiner S; Schuetz M; Geis NA; Kauczor HU; Bryant M; Chorianopoulos E; Pleger ST; Mereles D; Katus HA; Korosoglou G
J Invasive Cardiol; 2015 Mar; 27(3):172-80. PubMed ID: 25740972
[TBL] [Abstract][Full Text] [Related]
14. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
Stundl A; Lucht H; Shamekhi J; Weber M; Sedaghat A; Mellert F; Grube E; Nickenig G; Werner N; Sinning JM
PLoS One; 2019; 14(5):e0217544. PubMed ID: 31150455
[TBL] [Abstract][Full Text] [Related]
15. Sapien 3 Transcatheter Aortic Valve Implantation With Moderate or Without Predilation.
Abramowitz Y; Jilaihawi H; Chakravarty T; Maeno Y; Kawamori H; Kazuno Y; Mangat G; Rami T; Allison Z; Anderson D; Chan L; Cheng W; Makkar RR
J Invasive Cardiol; 2016 Oct; 28(10):421-426. PubMed ID: 27705892
[TBL] [Abstract][Full Text] [Related]
16. Transfemoral Aortic Valve Implantation with the New Edwards Sapien 3 Valve for Treatment of Severe Aortic Stenosis-Impact of Valve Size in a Single Center Experience.
Wöhrle J; Gonska B; Rodewald C; Seeger J; Scharnbeck D; Rottbauer W
PLoS One; 2016; 11(3):e0151247. PubMed ID: 27003573
[TBL] [Abstract][Full Text] [Related]
17. Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus.
Wendler O; Thielmann M; Schroefel H; Rastan A; Treede H; Wahlers T; Eichinger W; Walther T
Eur J Cardiothorac Surg; 2013 Feb; 43(2):371-7. PubMed ID: 22522982
[TBL] [Abstract][Full Text] [Related]
18. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
[TBL] [Abstract][Full Text] [Related]
19. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of balloon- versus mechanically-expandable transcatheter heart valves considering landing zone calcification.
Schofer N; Deuschl F; Schön G; Seiffert M; Linder M; Schaefer A; Schirmer J; Lubos E; Reichenspurner H; Blankenberg S; Conradi L; Schäfer U
J Cardiol; 2018 Jun; 71(6):540-546. PubMed ID: 29548665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
